Runway Growth Finance CEO taking medical leave of absence

Runway Growth Finance Corp. released the following statement: “David Spreng, Chairman, President, and CEO of Runway Growth will be taking a temporary leave of absence from the company in order to undergo treatment for a medical condition. Management and the Board send their thoughts and best wishes to David and his family. Runway Growth’s day-to-day operations will be uninterrupted. Thomas Raterman, CFO and COO of Runway Growth, has been appointed to acting President during David Spreng’s leave, in addition to his current responsibilities. Greg Greifeld, Deputy CIO and Head of Credit of Runway Growth Capital, LLC, Runway Growth’s investment adviser, has been appointed to acting CEO of Runway Growth. Julie Persily, Director and Chair of the Audit Committee, has been appointed to acting Chair of Runway Growth’s Board of Directors and permanently elected as the company’s Lead Independent Director. All three appointees have been with Runway Growth for over five years, fill important executive or governance positions currently, and possess deep institutional and industry expertise. The company will benefit from this continuation of leadership, and the executive team plans to advance Runway Growth’s strategy in the weeks to come.”